ACIU vs AMRN

ACIU's Advanced Deterministic Scorecard reveals severe financial distress: a Piotroski F-Score of 1/9 indicates extreme weakness in operational and financial health, while the absence of an Altman Z-Score raises unquantified bankruptcy risk. Despite a strong analyst consensus of 'strong_buy' and a target price of $8.98, the company exhibits catastrophic profitability metrics—negative ROE (-74.63%), gross and net margins at 0%, and a staggering -1671.88% operating margin. Revenue has collapsed by 96.3% YoY, and the stock trades at an absurd Price/Sales of 69.38, far exceeding peer benchmarks. The 52-week range ($1.43–$4.00) and 5-year decline of 62.7% underscore long-term underperformance, despite recent short-term price gains.

AMRN's Piotroski F-Score of 2/9 indicates severe financial distress, with weak profitability, declining revenue, and negative earnings trends. The absence of an Altman Z-Score raises concern about potential bankruptcy risk, especially given the company's negative ROE, ROA, and persistent losses despite a strong gross margin. While the company exhibits a low debt-to-equity ratio and high liquidity, these strengths are overshadowed by a 21% YoY revenue decline and a 94.7% Q/Q EPS drop. Analysts have issued a 'underperform' rating with a target price below current levels, reflecting skepticism about near-term sustainability. The stock's recent 87% 1-year gain is likely driven by speculative momentum rather than fundamentals.